Sarah, originally a Chicago native, graduated from the University of Denver with an Honors Science degree in 2012. She studied Cognitive Neuroscience, and worked with drosophila in a developmental neurobiology lab. She studied abroad in both England and Spain, which inspired her to pursue graduate studies in Montreal (The most “European city” in North America!). She is just starting her 1st year as a PhD Student, transferring after 2 years in the masters program. She currently investigates sex differences in chronic pain, as well as female-specific endogenous modulation of pain during pregnancy. Sarah is very passionate about inter-lab collaboration, especially among graduate students. Sarah is very active and enjoys the outdoors. She is a running enthusiast, but also loves biking and hiking.
Élora graduated from the University of Sherbrooke with a degree in biochemistry in 2012. Throughout the four internships of her undergraduate studies, with Prof. Philippe Sarret as her mentor, she studied the role of the glia in the modulation of spinal nociceptive processings. As a result of her studies and lab experience, she has developed a profound interest in the pain research field. She joined Prof. Sarret’s lab (Dept. of Pharmacology – Physiology, Université de Sherbrooke) as a Master’s student and transferred to the PhD program in 2015. Using a breast cancer bone metastasis model, she is investigating pharmacological and DsiRNA-based gene inhibition of the chemokinergic system in bone cancer pain management.
Jimena Perez Sanchez
Jimena obtained the Biology degree from the University of Queretaro in Mexico in 2010. Her interest in sensory systems lead her to pursue a Masters degree where she studied the modulation of tactile information and, especially, nociception. Under the supervision of Dr. Gerardo Rojas Piloni, she studied the mechanisms by which descending supraspinal systems regulate nociceptive information at the spinal cord level, in which spinal inhibitory interneurons take part. In order to continue her understanding the complex network of interneurons in the gating of pain, Jimena recently moved to Quebec to work under the supervision of Dr. Yves De Koninck at Laval University. Her PhD research focuses on the organization of the GABAergic and glycinergic inhibitory systems in the dorsal horn of the spinal cord and their regulation during chronic pain states.
Beatriz Monteiro received her veterinary degree at Sao Paulo State University (Unesp – Botucatu), Brazil. Following her graduation, she completed two different small animal internship programs at the University of Guelph, Canada. During that period she gained a great deal of clinical experience, but had also a strong desire to pursue an academic career. Dr. Monteiro is now a fully licensed veterinarian in Canada, and is currently doing a PhD in Pharmacology at the Faculty of Veterinary Medicine, University of Montreal under the supervision of Dr. Eric Troncy within the GREPAQ (Groupe de recherche en pharmacologie animale du Québec). Her research focuses in characterizing and treating chronic pain in dogs and cats. Most precisely, osteoarthritis and cancer-related pain.
Dr. Monteiro believes in novel, cutting-edge and translational research. She has a highly motivated attitude and strong work ethic. She loves animals, nature, and being with friends and family.
Élie earned a diploma in biochemistry, cell biology and physiology from Université de Franche-Comté (Besançon, France) in 2009; in 2010 he obtained his Bachelor in medical sciences from Université Claude Bernard – Lyon I (Villeurbanne, France). After eight months of internship at the Institute for Biology and Chemistry of Proteins (Lyon, France) where he studied the interaction between ABCG2 and the Human serum albumin in drug resistance, Élie decided to join the laboratory of Prof. R. Leduc (Dept. of Pharmacology) and Prof. P. Sarret (Dept. of Physiology and Biophysics) for his MSc in pharmacology in October 2010. He worked on the development of a BRET-Based assay for high throughput screening in collaboration with Tranzyme Pharma and Prof. M. Bouvier (U. Montréal). In 2012, Élie started his PhD in pharmacology working on the signalization of Neurotensin and Apelin receptors with the aim to discover new therapeutics for pain management.